| Income Statement |
| Total Revenue | 1.92B |
|
| Revenues (USD) | 1.92B |
| Cost of Revenue | 225.80M |
| Gross Profit | 1.70B |
| Operating Expenses | 203.61M |
| Research and Development Expense | 99.90M |
| Selling, General and Administrative Expense | 103.71M |
| Operating Income | 1.49B |
| Interest Expense | 51.16M |
| Income Tax Expense | 238.99M |
| Net Income | 1.27B |
| Net Income Common Stock | 1.27B |
| Net Income Common Stock (USD) | 1.27B |
| Consolidated Income | 1.27B |
| Earnings per Basic Share | 3.77 |
| Earnings per Basic Share (USD) | 3.77 |
| Earnings per Diluted Share | 3.76 |
| Earning Before Interest & Taxes (EBIT) | 1.56B |
| Earning Before Interest & Taxes (USD) | 1.56B |
| Weighted Average Shares | 335.80M |
| Weighted Average Shares Diluted | 337.03M |
| Balance Sheet |
| Cash and Equivalents | 3.05B |
| Cash and Equivalents (USD) | 3.05B |
| Investments | 289.96M |
| Investments Non-Current | 289.96M |
| Trade and Non-Trade Receivables | 2.17B |
| Current Assets | 5.39B |
| Property, Plant & Equipment Net | 111.95M |
| Total Assets | 8.27B |
| Total Debt | 3.52B |
| Current Liabilities | 1.25B |
| Debt Non-Current | 3.52B |
| Total Liabilities | 5.11B |
| Accumulated Retained Earnings (Deficit) | 2.66B |
| Accumulated Other Comprehensive Income | -73.81M |
| Shareholders Equity | 3.16B |
| Shareholders Equity (USD) | 3.16B |
| Assets Non-Current | 2.88B |
| Total Debt (USD) | 3.52B |
| Goodwill and Intangible Assets | 1.87B |
| Liabilities Non-Current | 3.85B |
| Trade and Non-Trade Payables | 778.94M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 32.56M |
| Net Cash Flow from Financing | -570.42M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 294.64M |
| Issuance (Purchase) of Equity Shares | -551.23M |
| Net Cash Flow from Investing | -2.44M |
| Net Cash Flow from Operations | 869.04M |
| Effect of Exchange Rate Changes on Cash | -1.54M |
| Share Based Compensation | 85.61M |